Results 251 to 260 of about 115,667 (333)
Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients. [PDF]
Neirotti A+11 more
europepmc +1 more source
ABSTRACT We investigated the value of measuring sFlt‐1/PlGF in people with suspected fetal growth restriction (sFGR) without signs of preeclampsia at recruitment. Angiogenic biomarkers were considered positive when sFlt‐1/PlGF > 38 or PlGF < 100 pg/mL. Clinicians were blinded to the sFlt‐1/PlGF results.
Ruth C. E. Hughes+4 more
wiley +1 more source
Multilayer Retinal Correspondence of the Structural and Vascular Anomalies in Eyes With Early Macular Telangiectasia Type 2. [PDF]
Krivosic V+5 more
europepmc +1 more source
Epidemiology of hypospadias in China: A nationwide surveillance‐based study, 2010–2020
Abstract Background The prevalence of hypospadias varied internationally. However, epidemiological data on hypospadias in contemporary China remain limited. Objectives We aim to examine the epidemiological characteristics of hypospadias in Chinese population.
Chen Zhiyu+7 more
wiley +1 more source
Dermatological Ultrasound of Less Frequent Dermatological Vascular Anomalies: A Retrospective Study and Literature Review From a Reference Center in Bogotá, Colombia. [PDF]
Gonzalez C+3 more
europepmc +1 more source
Abstract Background Anatomical variations in the mesoappendix and appendicular arteries play a crucial role in the development and management of appendicitis. This study aimed to analyze these variations and their clinical implications. Methods A retrospective analysis of 287 patients who underwent appendectomy was conducted.
Mehmet Torun+3 more
wiley +1 more source
Surgical treatment of hand vascular anomalies: A case report
Jefta Kozarski+4 more
openalex +2 more sources
Updates in Genetic Testing for Head and Neck Vascular Anomalies. [PDF]
Woodis KM+4 more
europepmc +1 more source
Australian‐born patients demonstrated the poorest 5‐year overall survival (52.3%) compared to immigrants born in East and South‐East Asia (66.9%), Middle East (73.9%), Europe (58.7%) and New Zealand and Pacific Islands (67.2%) for all colorectal cancer stages (log‐rank p < 0.001).
James A. Pasch+4 more
wiley +1 more source